Mufemilast
- Generic Name
- Mufemilast
- Drug Type
- Small Molecule
- Chemical Formula
- C20H22N2O7S2
- CAS Number
- 1255909-03-5
- Unique Ingredient Identifier
- 4QX9BK9E7P
Pharmacokinetic Interactions Between Hemay005 Tablets and Midazolam Maleate Tablets
- First Posted Date
- 2024-09-24
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Ganzhou Hemay Pharmaceutical Co., Ltd
- Target Recruit Count
- 20
- Registration Number
- NCT06610890
- Locations
- 🇨🇳
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Bioequivalence Test of Hemay005 Tablets
- First Posted Date
- 2024-09-24
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Ganzhou Hemay Pharmaceutical Co., Ltd
- Target Recruit Count
- 28
- Registration Number
- NCT06610903
- Locations
- 🇨🇳
Wuhan Central Hospital, Wuhan, Hubei, China
To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment
- First Posted Date
- 2024-04-23
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Ganzhou Hemay Pharmaceutical Co., Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT06380153
- Locations
- 🇨🇳
Union Hospital of Tongji Medical College; Huazhong University of Science and Technology, Wuhan, Hubei, China
To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage
- First Posted Date
- 2024-04-19
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Ganzhou Hemay Pharmaceutical Co., Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT06376474
- Locations
- 🇨🇳
Union Hospital of Tongji Medical College; Huazhong University of Science and Technology, Wuhan, Hubei, China
A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease
- First Posted Date
- 2023-11-24
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Ganzhou Hemay Pharmaceutical Co., Ltd
- Target Recruit Count
- 162
- Registration Number
- NCT06145893
- Locations
- 🇨🇳
Affiliated hospital of Guilin Medical university, Guilin, Guangxi, China
🇨🇳Linyi People's Hospital, Linyi, Shandong, China
🇨🇳Second hospital of shanxi medical university, Taiyuan, Shanxi, China
A Study of Hemay005 in Adult With Atopic Dermatitis
- First Posted Date
- 2023-03-15
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Ganzhou Hemay Pharmaceutical Co., Ltd
- Target Recruit Count
- 79
- Registration Number
- NCT05769946
- Locations
- 🇨🇳
First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis
- First Posted Date
- 2022-06-07
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Tianjin Hemay Pharmaceutical Co., Ltd
- Target Recruit Count
- 90
- Registration Number
- NCT05407246
- Locations
- 🇨🇳
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology, Wuhan, Hubei, China
🇨🇳Chenzhou first people's Hospital, Chenzhou, Hunan, China
🇨🇳The First Affiliated Hospital of Bengbu Medical University, Hefei, Anhui, China
Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Tianjin Hemay Pharmaceutical Co., Ltd
- Target Recruit Count
- 12
- Registration Number
- NCT04837235
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China
A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease
- First Posted Date
- 2020-10-30
- Last Posted Date
- 2022-06-21
- Lead Sponsor
- Tianjin Hemay Pharmaceutical Co., Ltd
- Target Recruit Count
- 89
- Registration Number
- NCT04609397
- Locations
- 🇨🇳
Peking University Shougang Hospital, Beijing, Beijing, China
🇨🇳Xuanwu Hospital Capital Medical University, Beijing, Beijing, China
🇨🇳Sun Yat-Sen Memorial Hospital,Sun Yat-Sen University, Guangzhou, Guangdong, China
A Food Effect Study to Assess Pharmacokinetics of Hemay005 in Healthy Volunteers
- First Posted Date
- 2018-07-05
- Last Posted Date
- 2018-07-05
- Lead Sponsor
- Tianjin Hemay Bio-Tech Co., Ltd
- Target Recruit Count
- 12
- Registration Number
- NCT03577626
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.